Coating material as well as preparation method and application thereof

By applying nano-grade phospholipid-modified polypyrrolidone copolymer nanoparticles coating materials on the surface of the heart valve, the immune rejection, coagulation and calcification problems after valve transplantation are solved, the biocompatibility and mechanical properties of the valve are improved, and the biocompatibility and mechanical properties of the valve are extended. The service life of the valve improves the quality of life of patients.

CN118924952APending Publication Date: 2024-11-12NANJING SAINT MEDICAL TECH CO LTD +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410780935.X
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-06-18
Publication Date
2024-11-12

AI Technical Summary

Technical Problem

Existing heart valves are prone to trigger immune rejection, coagulation and calcification after allograft, resulting in structural and functional instability and affecting the patient's quality of life.

Method used

Nano-grade phospholipid-modified polypyrrolidone copolymer nanoparticles are used as coating material, and a stable biocompatible coating is formed on the valve surface through ultraviolet curing technology to enhance anticoagulation and anti-calcification properties.

Benefits of technology

It significantly improves the biocompatibility and mechanical properties of the valve, extends the service life of the valve, reduces the risk of immune rejection, and improves the quality of life of patients.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0004897084100000071
    Figure BDA0004897084100000071
  • Figure BDA0004897084100000081
    Figure BDA0004897084100000081
  • Figure BDA0004897084100000082
    Figure BDA0004897084100000082
Patent Text Reader

Abstract

The invention discloses a preparation method of a coating material, which comprises the following components in percentage by weight: main active substances and the balance of auxiliary reagents, the preparation method of the main active substance comprises the following steps: dissolving polypyrrolidone in water, adding an amphiphilic monomer, stirring, adding an initiator, and stirring to obtain modified polypyrrolidone; dispersing phospholipid molecules in an organic acid solution, then adding the modified polypyrrolidone, stirring, and carrying out freeze drying and grinding treatment on the obtained solid product to obtain a main active substance; the preparation method of the auxiliary reagent comprises the following steps: respectively adding the flatting agent, the photoinitiator and the adhesion promoter into the glycerol in parts by weight, and fully and uniformly stirring to obtain the auxiliary reagent. The coating material provided by the invention is used for valve surface modification, and can further improve the anticoagulant property and anti-calcification property of the valve on the premise of ensuring excellent mechanical properties and biocompatibility of the valve.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention belongs to the technical field of valve modification, and in particular, relates to a coating material for a valve and a preparation method and application thereof. Background Art

[0002] In order for an artificial heart valve to be successfully transplanted into the human body and to perform functions similar to those of a natural valve in a long-term and stable manner, and to ensure the normal life activities of the body, it must have physical and chemical properties similar to those of a natural valve. An ideal artificial heart valve must meet the following conditions to support its function in the body: 1) Compatibility, that is, no immune rejection reaction occurs after the valve is transplanted into the body; 2) Anticoagulability, which can ensure that the transplanted valve does not cause local thrombosis or coagulation in the body; 3) Anti-calcification, good anti-calcification can reduce the risk of thickening of the valve leaflets, thereby ensuring the normal opening and closing of the valve; 4) Excellent mechanical properties, which are the key to ensuring the normal opening and closing of the valve; 5) Durability, the transplanted valve needs to function in the body for a long time.

[0003] At present, the more common valve types include mechanical valves, biological valves, and polymer valves. However, no matter which type of valve, there is a risk of infection, immune rejection, cytotoxicity, hemotoxicity, and difficulty in maintaining stable structure and function after allogeneic transplantation. In order to ensure the smooth progress of the transplant, it is usually necessary to modify the transplanted valve before transplantation to change the surface properties of the valve, so as to exert good compatibility, anticoagulant and anti-calcification properties in the transplanted body. Further improve the survival time of the valve in the body, avoid the patient from being affected by allogeneic rejection, reduce the frequency of re-implantation surgery, and improve the patient's quality of life. Summary of the invention

[0004] The purpose of the present invention is to overcome the problems existing in the prior art and provide a coating material and a preparation method and application thereof. The coating material of the present invention has good mechanical properties and biocompatibility, and is used for valve modification, which can not only ensure the excellent mechanical properties and biocompatibility of the valve, but also further improve the anti-coagulation and anti-calcification properties of the valve.

[0005] The purpose of the present invention and the solution to the technical problem are achieved by adopting the following technical solutions.

[0006] One aspect of the present invention provides a method for preparing a coating material, wherein the coating material comprises 30-40% of a main active substance and the remainder of an auxiliary agent in terms of weight percentage; wherein:

[0007] The preparation method of the main active substance comprises the following steps:

[0008] Dissolving polypyrrolidone in water to obtain a polypyrrolidone aqueous solution with a concentration of 60 to 80 wt%, adding an amphiphilic monomer and stirring for 10 to 30 minutes, then adding an initiator and stirring at 40 to 60° C. for 30 to 60 minutes, and after the reaction is completed, obtaining a modified polypyrrolidone;

[0009] The phospholipid molecules are dispersed in a 5-10 mol / L organic acid solution to obtain a phosphatidic acid solution with a concentration of 40-60 wt%, and then the system is heated to 50-100° C., and modified polypyrrolidone is added and stirred to react for 20-40 minutes. After the reaction is completed, it is cooled to room temperature, and then allowed to stand for 1-3 hours, filtered, and the obtained solid product is freeze-dried and ground to obtain nano-scale phospholipid-encapsulated modified polypyrrolidone copolymer nanoparticles, which are the main active substance;

[0010] The preparation method of the auxiliary reagent comprises the following steps:

[0011] According to weight fractions, add 2 to 8 parts of leveling agent, 5 to 10 parts of photoinitiator and 1 to 3 parts of adhesion promoter into 100 parts of glycerin respectively, stir well and obtain the product.

[0012] In a preferred embodiment of the present invention, the amphiphilic monomer is selected from dimethylaminoethyl methacrylate, hydroxypropyl methacrylate, hydroxyethyl methacrylate, or a mixture of two or more thereof.

[0013] In a preferred embodiment of the present invention, the amount of the amphiphilic monomer added is 1 to 2 times the mass of the polypyrrolidone.

[0014] In a preferred embodiment of the present invention, the initiator includes one or a mixture of two or more of azobisisobutylimidazoline hydrochloride, azobisisobutylamidine hydrochloride, azobisisobutyronitrile, azobisisoheptanenitrile and azobisisovaleronitrile.

[0015] In a preferred embodiment of the present invention, the added amount of the initiator is 0.01 to 0.05 times the mass of the polypyrrolidone.

[0016] In a preferred embodiment of the present invention, the phospholipid molecules are selected from one or a mixture of two or more of soybean lecithin, egg yolk lecithin, phosphatidylinositol diphosphate, distearoylphosphatidylglycerol, distearoylphosphatidylcholine, dipalmitoylphosphatidylcholine and dimyristoylphosphatidylcholine.

[0017] In a preferred embodiment of the present invention, the organic acid is selected from one or a mixture of two or more of acetic acid, oxalic acid, citric acid, salicylic acid, and tartaric acid.

[0018] In a preferred embodiment of the present invention, the modified polypyrrolidone is added in an amount with a molecular weight ratio of 1:2 to 3 with respect to the phospholipid.

[0019] In a preferred embodiment of the present invention, the photoinitiator is selected from any one of benzil, benzophenone, thioxanthone, anthraquinone, benzoylformate, acylphosphine oxide, aryl diazonium salt, diaryl iodonium salt, and triaryl sulfonium salt.

[0020] In a preferred embodiment of the present invention, the leveling agent is selected from any one of BYK-378, BYK-3560, BYK-333, and BYK-UV 3500; and the adhesion promoter is PM-2 or EM39.

[0021] By means of the above technical solution, the present invention has at least the following advantages:

[0022] The coating material of the present invention uses nano-scale phospholipid-modified polypyrrolidone copolymer nanoparticles as the main active substance. Through the auxiliary effect of auxiliary reagents, the surface coating is treated before the valve is transplanted, so that the valve can obtain excellent biocompatibility, anti-coagulation and anti-calcification properties.

[0023] The main active substance of the present invention can be firmly attached to the valve surface through the action of ultraviolet light and auxiliary agents. The coating material of the present invention is packaged in categories to ensure the stability of the performance of the main active substance. When used, the main active substance and the auxiliary agent need to be mixed in proportion, and then the valve is immersed in the mixed liquid and cured under the action of ultraviolet light to obtain a valve with the coating material coated on the surface.

[0024] The main active substance of the present invention is to use polypyrrolidone as a polymer carrier, introduce an amphiphilic monomer under the action of an initiator, obtain a grafted modified polypyrrolidone, encapsulate the grafted modified polypyrrolidone with phospholipid molecules in an acidic environment, form a material of a stable system-phospholipid encapsulated modified polypyrrolidone copolymer, and finally obtain nano-scale phospholipid encapsulated modified polypyrrolidone copolymer nanoparticles through drying and grinding. When the material is used for valve coating, the amount and rate of adhesion on the valve surface can be increased. The encapsulation of phospholipid molecules can provide the biocompatibility of the material. The obtained coating material not only has good biocompatibility, but also can prevent the aggregation of water-soluble calcium ions and platelets. The valve transplanted into the body can maintain vitality for a long time, avoid the generation of immune rejection reaction, thereby achieving the purpose of keeping the patient's body normal and improving the patient's quality of life.

[0025] The above description is only an overview of the technical solution of the present invention. In order to more clearly understand the technical means of the present invention and implement it according to the contents of the specification, the preferred embodiments of the present invention are described in detail as follows. DETAILED DESCRIPTION

[0026] In order to make the technical means, creative features, objectives and effects of the present invention easy to understand, the technical solutions in the embodiments of the present invention will be clearly and completely described below in combination with the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of them. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0027] Unless otherwise specified, the experimental methods used in the following examples are all conventional methods.

[0028] Unless otherwise specified, the materials and reagents used in the following examples can be obtained from commercial sources.

[0029] Embodiment 1:

[0030] Preparation of the main active substance: Dissolve polypyrrolidone in water to obtain a polypyrrolidone aqueous solution with a concentration of 70wt%, add dimethylaminoethyl methacrylate (the amount added is 1.5 times the mass of polypyrrolidone) and stir for 20min, then add azobisisoheptanenitrile (the amount added is 0.03 times the mass of polypyrrolidone) and stir for 45min at 50°C, and after the reaction is completed, obtain modified polypyrrolidone. Disperse soybean lecithin in 7.5mol / L acetic acid solution to obtain a 50wt% phosphatidic acid solution, then heat the system to 75°C, add modified polypyrrolidone (added in an amount of 1:2.5 with soybean lecithin) and stir for 30min, after the reaction is completed, cool to room temperature, then stand for 2h, filter, freeze-dry and grind the obtained solid product to obtain nano-scale soybean lecithin encapsulated modified polypyrrolidone copolymer nanoparticles, which are the main active substance.

[0031] Preparation of auxiliary reagents: According to weight percentage, add 4 parts of leveling agent BYK-378, 7.5 parts of benzoyl formate, and 2 parts of adhesion promoter PM-2 to 100 parts of glycerol respectively, and stir well to obtain auxiliary reagents.

[0032] Preparation of coating material: The coating material includes 35% of a main active substance and the remainder of an auxiliary agent in terms of weight percentage, wherein the main active substance and the auxiliary agent are packaged separately.

[0033] Embodiment 2:

[0034] Preparation of the main active substance: dissolve polypyrrolidone in water to obtain a polypyrrolidone aqueous solution with a concentration of 60wt%, add hydroxypropyl methacrylate (the amount added is 1 times the mass of polypyrrolidone) and stir for 10min, then add azobisisobutylamidine hydrochloride (the amount added is 0.01 times the mass of polypyrrolidone) and stir for 30min at 60°C, after the reaction is completed, obtain modified polypyrrolidone. Disperse phosphatidylinositol diphosphate in 10mol / L oxalic acid solution to obtain a phosphatidic acid solution with a concentration of 60wt%, then heat the system to 50°C, add modified polypyrrolidone (added in an amount of 1:3 with phosphatidylinositol diphosphate) and stir for 40min, after the reaction is completed, cool to room temperature, then stand for 1h, filter, freeze-dry and grind the obtained solid product to obtain nano-scale phosphatidylinositol diphosphate encapsulated modified polypyrrolidone copolymer nanoparticles, which are the main active substance.

[0035] Preparation of auxiliary reagents: According to weight percentage, add 8 parts of leveling agent BYK-3560, 10 parts of thioxanthone, and 3 parts of adhesion promoter PM-2 to 100 parts of glycerol respectively, and stir well to obtain auxiliary reagents.

[0036] Preparation of coating material: The coating material includes 40% of a main active substance and the remainder of an auxiliary agent in terms of weight percentage, wherein the main active substance and the auxiliary agent are packaged separately.

[0037] Embodiment 3:

[0038] Preparation of the main active substance: dissolve polypyrrolidone in water to obtain a polypyrrolidone aqueous solution with a concentration of 80wt%, add hydroxyethyl methacrylate (the amount added is 2 times the mass of polypyrrolidone) and stir for 30min, then add azobisisobutylimidazoline hydrochloride (the amount added is 0.05 times the mass of polypyrrolidone) and stir for 60min at 40°C, and after the reaction is completed, obtain modified polypyrrolidone. Distearoylphosphatidylcholine is dispersed in 5mol / L citric acid solution to obtain a phosphatidic acid solution with a concentration of 40wt%, then the system is heated to 100°C, and modified polypyrrolidone (added in an amount of 1:2 with distearoylphosphatidylcholine) is added and stirred for 20min, after the reaction is completed, it is cooled to room temperature, then allowed to stand for 3h, filtered, and the obtained solid product is freeze-dried and ground to obtain nano-scale distearoylphosphatidylcholine encapsulated modified polypyrrolidone copolymer nanoparticles, which are the main active substance.

[0039] Preparation of auxiliary reagents: According to weight percentage, add 2 parts of leveling agent BYK-333, 5 parts of benzophenone, and 1 part of adhesion promoter PM-2 to 100 parts of glycerin respectively, and stir well to obtain auxiliary reagents.

[0040] Preparation of coating material: The coating material includes 30% of a main active substance and the remainder of an auxiliary agent in terms of weight percentage, wherein the main active substance and the auxiliary agent are packaged separately.

[0041] Embodiment 4:

[0042] Preparation of the main active substance: dissolve polypyrrolidone in water to obtain a polypyrrolidone aqueous solution with a concentration of 70wt%, add hydroxyethyl methacrylate (the amount added is 2 times the mass of polypyrrolidone) and stir for 20min, then add azobisisobutyronitrile (the amount added is 0.02 times the mass of polypyrrolidone) and stir for 40min at 50°C, after the reaction is completed, obtain modified polypyrrolidone. Distearoylphosphatidylglycerol is dispersed in 8mol / L salicylic acid solution to obtain a phosphatidic acid solution with a concentration of 40wt%, then the system is heated to 80°C, and modified polypyrrolidone (added in an amount of 1:2 with distearoylphosphatidylglycerol) is added and stirred for 30min, after the reaction is completed, it is cooled to room temperature, then allowed to stand for 3h, filtered, and the obtained solid product is freeze-dried and ground to obtain nano-scale distearoylphosphatidylglycerol encapsulated modified polypyrrolidone copolymer nanoparticles, which are the main active substance.

[0043] Preparation of auxiliary reagents: According to weight percentage, add 6 parts of leveling agent BYK-UV 3500, 8 parts of anthraquinone, and 2 parts of adhesion promoter PM-2 to 100 parts of glycerol respectively, and stir well to obtain auxiliary reagents.

[0044] Preparation of coating material: The coating material includes 35% of a main active substance and the balance of an auxiliary agent in terms of weight percentage, wherein the main active substance and the auxiliary agent are packaged separately.

[0045] Comparative Example 1:

[0046] Preparation of the main active substance: polypyrrolidone is dissolved in water to obtain a polypyrrolidone aqueous solution with a concentration of 70wt%, dimethylaminoethyl methacrylate (the amount added is 1.5 times the mass of polypyrrolidone) is added and stirred for 20 minutes, and then azobisisoheptanenitrile (the amount added is 0.03 times the mass of polypyrrolidone) is added and stirred for reaction at 50°C for 45 minutes. After the reaction is completed, the solid product is filtered and freeze-dried and ground to obtain nano-scale modified polypyrrolidone copolymer nanoparticles, which are the main active substance.

[0047] Preparation of auxiliary reagents: According to weight percentage, add 4 parts of leveling agent BYK-378, 7.5 parts of benzoyl formate, and 2 parts of adhesion promoter PM-2 to 100 parts of glycerol respectively, and stir well to obtain auxiliary reagents.

[0048] Preparation of coating material: The coating material includes 35% of a main active substance and the remainder of an auxiliary agent in terms of weight percentage, wherein the main active substance and the auxiliary agent are packaged separately.

[0049] Comparative Example 2:

[0050] Preparation of the main active substance: soybean lecithin is dispersed in 7.5 mol / L acetic acid solution to obtain a phosphatidic acid solution with a concentration of 50 wt%, and then the system is heated to 75°C, polypyrrolidone is added (added in an amount of 1:2.5 with the mass ratio of soybean lecithin) and stirred for reaction for 30 minutes. After the reaction is completed, it is cooled to room temperature, then allowed to stand for 2 hours, filtered, and the obtained solid product is freeze-dried and ground to obtain nano-scale soybean lecithin-encapsulated polypyrrolidone copolymer nanoparticles, which are the main active substance.

[0051] Preparation of auxiliary reagents: According to weight percentage, add 4 parts of leveling agent BYK-378, 7.5 parts of benzoyl formate, and 2 parts of adhesion promoter PM-2 to 100 parts of glycerol respectively, and stir well to obtain auxiliary reagents.

[0052] Preparation of coating material: The coating material includes 35% of a main active substance and the remainder of an auxiliary agent in terms of weight percentage, wherein the main active substance and the auxiliary agent are packaged separately.

[0053] Comparative Example 3:

[0054] Preparation of the main active substance: Dissolve polypyrrolidone in water to obtain a polypyrrolidone aqueous solution with a concentration of 70wt%, add dimethylaminoethyl methacrylate (the amount added is 1.5 times the mass of polypyrrolidone) and stir for 20min, then add azobisisoheptanenitrile (the amount added is 0.03 times the mass of polypyrrolidone) and stir for 45min at 50°C, and after the reaction is completed, obtain modified polypyrrolidone. Disperse soybean lecithin in 7.5mol / L acetic acid solution to obtain a 50wt% phosphatidic acid solution, then heat the system to 75°C, add modified polypyrrolidone (added in an amount of 1:2.5 with soybean lecithin) and stir for 30min, after the reaction is completed, cool to room temperature, then stand for 2h, filter, freeze-dry and grind the obtained solid product to obtain nano-scale soybean lecithin encapsulated modified polypyrrolidone copolymer nanoparticles, which are the main active substance.

[0055] Preparation auxiliary reagents: glycerol.

[0056] Preparation of coating material: According to weight percentage, the coating material includes 35% of a main active substance and the balance of an auxiliary agent, glycerol, wherein the main active substance and the auxiliary agent are packaged separately.

[0057] Comparative Example 4:

[0058] Preparation of coating material: According to weight fraction, add 4 parts of leveling agent BYK-378, 7.5 parts of benzoyl formate, and 2 parts of adhesion promoter PM-2 into 100 parts of glycerol respectively, and stir well to obtain the coating material.

[0059] Application Example 1: Tensile Strength and Hemolytic Tests of Valves Made of Different Coating Materials

[0060] Preparation of coating materials: The main active substances and auxiliary agents in Examples 1-4 and Comparative Examples 1-3 are mixed evenly according to the proportions to obtain corresponding coating materials. The coating material of Comparative Example 4 can be used directly.

[0061] Preparation of valves with surface coating: 8 substantially identical pig pericardiums were taken as valves to be transplanted and numbered 1-8. Pretreatment was required before coating: first, excess fat and blood vessels on the surface of the pig pericardium were removed, and then washed with physiological saline for 2 hours. Then, the coating material obtained according to Examples 1-4 and Comparative Examples 1-4 was applied to pig pericardiums 1-8, and then heated at 20 mW / cm 2 The mixture was cured under ultraviolet light intensity of 10 min to obtain surface-coated pig pericardium No. 1-8.

[0062] Tensile strength test: Samples of equal size were cut from the surface-coated valves No. 1 to No. 8, and mechanical properties were tested using a universal testing machine at room temperature to determine their tensile strength.

[0063] Hemolytic test: Soak the coated valves No. 1-8 in platelet-rich plasma, incubate at 37°C for 2 hours, and then rinse 3 times with phosphate-buffered saline to remove non-adherent platelets. Calculate hemolytic activity according to ISO TR7405.

[0064] The results are shown in Table 1. From the results in Table 1, it can be seen that compared with valves 5-8, valves 1-4 have better tensile strength and lower hemolysis, which shows that the coating materials prepared in Examples 1-4 of the present invention can improve the biocompatibility and mechanical properties of the valve when used for valve surface coating.

[0065] Table 1 Statistics of hemolytic activity of valves with different surface coatings

[0066]

[0067]

[0068] Application Example 2: Detection of calcium content in valves made of different coating materials

[0069] The valves No. 1-8 with the surface coating obtained in Application Example 1 were subjected to a calcification test. The specific operation was as follows: the valves No. 1-8 were cut into 1cm×1cm in size, and then implanted on both sides of the subcutaneous tissue of the mouse back. Eight young SD rats about 20 days old were arranged for this experiment. Before implantation, the rats were anesthetized by injecting 0.1mL of 3% sodium pentobarbital. Four weeks after transplantation, the animals were euthanized by cervical dislocation and the grafts were removed. After the samples were taken out, they were rinsed with saline. After freeze-drying, the dry weight was weighed, and then 6N concentrated hydrochloric acid was used to digest in a 90°C water bath until there were no visible solid particles, and then an inductively coupled plasma emission spectrometer was used for quantitative analysis of calcium.

[0070] The results are shown in Table 2. From the results in Table 2, it can be seen that compared with valves 5-8, valves 1-4 have lower calcium content, which shows that the coating material prepared by Examples 1-4 of the present invention has a significantly improved anti-calcification ability of the valve when used for valve surface coating.

[0071] Table 2 Statistics of calcium levels in different valves

[0072]

[0073]

[0074] The above description is only a preferred embodiment of the present invention and does not limit the present invention in any form. Although the present invention has been disclosed as a preferred embodiment as above, it is not used to limit the present invention. Any technician familiar with this profession can make some changes or modifications to equivalent embodiments of equivalent changes by using the methods and technical contents disclosed above without departing from the scope of the technical solution of the present invention. However, any simple modification, equivalent change and modification made to the above embodiments according to the technical essence of the present invention without departing from the content of the technical solution of the present invention still fall within the scope of the technical solution of the present invention.

Claims

1. A method for preparing a coating material, characterized in that: In terms of weight percentage, the coating material includes 30-40% of the main active substance and the balance of auxiliary agents; wherein, The preparation method of the main active substance comprises the following steps: Dissolving polypyrrolidone in water to obtain a polypyrrolidone aqueous solution with a concentration of 60 to 80 wt%, adding an amphiphilic monomer and stirring for 10 to 30 minutes, then adding an initiator and stirring at 40 to 60° C. for 30 to 60 minutes, and after the reaction is completed, obtaining a modified polypyrrolidone; The phospholipid molecules are dispersed in a 5-10 mol / L organic acid solution to obtain a phosphatidic acid solution with a concentration of 40-60 wt%, and then the system is heated to 50-100° C., and modified polypyrrolidone is added and stirred to react for 20-40 minutes. After the reaction is completed, it is cooled to room temperature, and then allowed to stand for 1-3 hours, filtered, and the obtained solid product is freeze-dried and ground to obtain nano-scale phospholipid-encapsulated modified polypyrrolidone copolymer nanoparticles, which are the main active substance; The preparation method of the auxiliary reagent comprises the following steps: According to weight fractions, add 2 to 8 parts of leveling agent, 5 to 10 parts of photoinitiator and 1 to 3 parts of adhesion promoter into 100 parts of glycerin respectively, stir well and obtain the product.

2. The preparation method according to claim 1, characterized in that: The amphiphilic monomer is selected from dimethylaminoethyl methacrylate, hydroxypropyl methacrylate, hydroxyethyl methacrylate, or a mixture of two or more thereof.

3. The preparation method according to claim 1 or 2, characterized in that: The amount of the amphiphilic monomer added is 1 to 2 times the mass of the polypyrrolidone.

4. The preparation method according to claim 1, characterized in that: The initiator comprises one or a mixture of two or more of azobisisobutylimidazoline hydrochloride, azobisisobutylamidine hydrochloride, azobisisobutyronitrile, azobisisoheptanenitrile and azobisisovaleronitrile.

5. The preparation method according to claim 1 or 4, characterized in that: The added amount of the initiator is 0.01 to 0.05 times the mass of the polypyrrolidone.

6. The preparation method according to claim 1, characterized in that: The phospholipid molecules are selected from one or a mixture of two or more of soybean lecithin, egg yolk lecithin, phosphatidylinositol diphosphate, distearoylphosphatidylglycerol, distearoylphosphatidylcholine, dipalmitoylphosphatidylcholine and dimyristoylphosphatidylcholine.

7. The preparation method according to claim 1, characterized in that: The organic acid is selected from one of acetic acid, oxalic acid, citric acid, salicylic acid and tartaric acid or a mixture of two or more thereof.

8. The preparation method according to claim 1, characterized in that: The modified polypyrrolidone is added in an amount with a molecular weight ratio of 1:2 to 3 with respect to the phospholipid.

9. The preparation method according to claim 1, characterized in that: The photoinitiator is selected from any one of benzil, benzophenone, thioxanthone, anthraquinone, benzoylformate, acylphosphine oxide, aryl diazonium salt, diaryl iodonium salt and triaryl sulfonium salt.

10. The preparation method according to claim 1, characterized in that: The leveling agent is selected from any one of BYK-378, BYK-3560, BYK-333, and BYK-UV 3500; and the adhesion promoter is PM-2 or EM39.